Contact this trialFirst, we need to learn more about you.
Thrombopoietin Receptor Agonist
Eltrombopag vs Standard Treatment for ITP in Children
Recruiting3 awardsPhase 3
Memphis, Tennessee
This trial tests eltrombopag, a drug that helps make more platelets, in children with a specific blood condition. The goal is to see if it works better than standard treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service